John Pippin. Animal Research in Medical Sciences: Seeking a Convergence of Science, Medicine, and Animal Law. South Texas Law Review. 2012;54:469. https://www.wellbeingintlstudiesrepository.org/acwp_all/14.
Myfanwy Morgan, Christine A. Barry, Jenny L. Donovan, Jane Sandall, Charles D. A. Wolfe, Annette Boaz. Implementing ‘translational’ biomedical research: Convergence and divergence among clinical and basic scientists. Social Science & Medicine. 2011;73(7):945-952. doi:10.1016/j.socscimed.2011.06.060
Matthew M. Davis, Amy T. Butchart, John R. C. Wheeler, Margaret S. Coleman, Dianne C. Singer, Gary L. Freed. Failure-to-success ratios, transition probabilities and phase lengths for prophylactic vaccines versus other pharmaceuticals in the development pipeline. Vaccine. 2011;29(51):9414-9416. doi:10.1016/j.vaccine.2011.09.128
Niall Shanks, Ray Greek, Jean Greek. Are animal models predictive for humans?. Philosophy, ethics, and humanities in medicine: PEHM. 2009;4:2. doi:10.1186/1747-5341-4-2
Robert A. J. Matthews. Medical progress depends on animal models - doesn’t it?. Journal of the Royal Society of Medicine. 2008;101(2):95-98. doi:10.1258/jrsm.2007.070164
Pablo Perel, Ian Roberts, Emily Sena, et al. Comparison of treatment effects between animal experiments and clinical trials: systematic review. BMJ. 2007;334:197. doi:10.1136/bmj.39048.407928.BE
Victoria E. O’Collins, Malcolm R. Macleod, Geoffrey A. Donnan, Laura L. Horky, Bart H. van der Worp, David W. Howells. 1,026 experimental treatments in acute stroke. Annals of Neurology. 2006;59(3):467-477. doi:10.1002/ana.20741
Pandora Pound, Shah Ebrahim, Peter Sandercock, Michael B Bracken, Ian Roberts. Where is the evidence that animal research benefits humans?. BMJ. 2004;328:514-517. doi:10.1136/bmj.328.7438.514
Peter J.K. van Meer, Marlous Kooijman, Christine C. Gispen-de Wied, Ellen H.M. Moors, Huub Schellekens. The ability of animal studies to detect serious post marketing adverse events is limited. Regulatory Toxicology and Pharmacology. 64(3):345-349. doi:10.1016/j.yrtph.2012.09.002
Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM) Validation Workgroup. Validation, Qualification, and Regulatory Acceptance of New Approach Methodologies. Interagency Coordinating Committee on the Validation of Alternative Methods; :75. https://ntp.niehs.nih.gov/sites/default/files/2024-03/VWG_Report_27Feb2024_FD_508.pdf.